FIELD: organic chemistry, biology, pharmacy.
SUBSTANCE: invention relates to derivatives of thieno[2,3-d]pyrimidine of the general formula (I): or their pharmaceutically acceptable salts wherein R1 and R2 in common with nitrogen atom to which they are added form a ring comprising from 2 to 6 carbon atoms and optionally comprising one or more heteroatoms chosen from nitrogen (N), oxygen (O) and/or sulfur (S) atoms. Proposed compounds possess ability to activate both luteinizing hormone (LH) and follicle-stimulating hormone (FSH) and can be used in therapy in aims for regulating fertility. Also, invention describes a pharmaceutical composition based on compounds of the formula (I).
EFFECT: valuable biological and medicinal properties of compounds and pharmaceutical composition.
6 cl, 1 tbl, 7 ex
Title | Year | Author | Number |
---|---|---|---|
GLYCINE-SUBSTITUTED THIENO[2,3-D]PYRIMIDINES WITH COMBINED LH- AND FSH-AGONISTIC ACTIVITY | 2002 |
|
RU2294331C2 |
BICYCLIC HETEROAROMATIC COMPOUNDS, PHARMACEUTICAL COMPOSITION BASED ON THEREOF AND USING | 2001 |
|
RU2271360C2 |
BICYCLIC HETEROAROMATIC COMPOUNDS AS LH AGONISTS AND PHARMACEUTICAL COMPOSITION | 2000 |
|
RU2248979C2 |
NEW GLP-1 RECEPTOR MODULATORS | 2012 |
|
RU2634896C2 |
TETRAHYDROQUINOLIN DERIVATIVES, BASED PHARMACEUTICAL COMPOSITION BASED ON THEM AND THEIR APPLICATION AS FERTILITY MODULATOR | 2003 |
|
RU2328488C2 |
CERTAIN PROTEIN KINASE INHIBITORS | 2015 |
|
RU2671494C2 |
DIHYDROPYRIDINE DERIVATIVES | 2005 |
|
RU2372337C2 |
SUBSTITUTED PYRROLES ACTIVE AS KINASES INHIBITORS | 2013 |
|
RU2666538C2 |
HETEROARYL COMPOUNDS AS IRAK TYPE II INHIBITORS AND THEIR USE | 2019 |
|
RU2810338C2 |
THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND METHODS OF USING THEM | 2018 |
|
RU2769696C2 |
Authors
Dates
2007-04-27—Published
2002-08-29—Filed